Emerging indications for cardiac pacing

Heart Disease

Volumn 3, Issue 4, 2001, Pages 224-230

  Slotwiner, D J ^a   Stein, K M ^a   Markowitz, S M ^a   Mittal, S ^a   Iwai, S ^a   Das, M ^a   Lerman, B B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Congestive heart failure; Hypertrophic obstructive cardiomyopathy; Neurally mediated syncope; Pacemaker

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CONGESTIVE HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART PACING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; REVIEW; SINUS NODE DYSFUNCTION; SYNCOPE; TREATMENT INDICATION;

EID: 0035204315     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200107000-00004     Document Type: Review

References (58)

1. An implantable pacemaker for the heart
2. ACC/AHA Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary
3. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results
4. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study
5. Midodrine: A role in the management of neurocardiogenic syncope
6. Efficacy of midodrine hydrochloride in neuro-cardiogenic syncope refractory to standard therapy
7. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope
8. The use of head-upright tilt table testing in the evaluation and management of syncope in children and adolescents
9. A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
10. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: Pacemaker versus no therapy, A multicenter randomized study
11. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope
12. Permanent pacing for cardioinhibitory malignant vasovagal syndrome
13. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope
14. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt
15. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, cross-over study (M-PATHY)
16. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
17. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy
18. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
19. Mechanical remodeling of the left atrium after loss of atrioventricular synchrony: A long-term study in humans
20. Electrical remodeling of the atria following loss of atrioventricular synchrony: A long-term study in humans
21. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes
22. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome
23. Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing
24. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing
25. Atrioventricular conduction during long-term follow-up of patients with sick sinus syndrome
26. Atrial pacing and the risk for AV block: Is there a time for change in attitude?
27. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy
28. Usefulness of physiologic dual-chamber pacing in drag-resistant idiopathic dilated cardiomyopathy
29. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: An acute Doppler and catheterization hemodynamic study
30. VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure
31. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: A randomized study
32. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure
33. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony
34. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay
35. Evaluation of different ventricular pacing sites in patients with severe heart failure: Results of an acute hemodynamic study
36. Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync Study
37. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure
38. Left ventricular-based pacing in patients with chronic heart failure: Comparison of acute hemodynamic benefits according to underlying heart disease
39. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation
40. Ventricular contraction abnormalities in dilated cardiomyopathy: Effect of biventricular pacing to correct interventricular dyssynchrony
41. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay
42. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: Rationale, design, and endpoints of a prospective randomized multicenter study
43. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay
44. Biventricular pacing in patients with congestive heart failure: Two prospective randomized trials
45. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention
46. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
47. Atrial septal pacing: A method for pacing both atria simultaneously
48. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation
49. Effects of different atrial pacing modes on atrial electrophysiology: Implicating the mechanism of biatrial pacing in prevention of atrial fibrillation
50. Prevention of chronic atrial fibrillation by pacing at Bachman's bundle: Results of a randomized prospective multicenter study
51. Biatrial synchronous pacing for atrial arrhythmia prevention: The SYNBLAPACE study
52. Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial
53. Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery
54. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery
55. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery
56. Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting
57. Multicenter InSync Randomized Clinical Evaluation (MIRACLE): Results of a randomized, double-blind, controlled trial to assess cardiac resynchronization patients
58. Cardiac resynchronization therapy: Results of the CONTAK CD study